Cours Sonoma Pharmaceuticals Inc Nasdaq
Actions
US83558L1052
Produits pharmaceutiques
CA 2024 * | 14,7 M 13,53 M | CA 2025 * | 17,9 M 16,48 M | Capitalisation | 2,48 M 2,28 M |
---|---|---|---|---|---|
Résultat net 2024 * | -5 M -4,6 M | Résultat net 2025 * | -3 M -2,76 M | VE / CA 2024 * | 0,17 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 0,14 x |
PER 2024 * |
-0,18
x | PER 2025 * |
-0,35
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 98,44% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Amy Trombly
CEO | Chief Executive Officer | 57 | 27/09/19 |
John Poggetto
DFI | Director of Finance/CFO | 53 | 01/01/02 |
Jerome Dvonch
DFI | Director of Finance/CFO | 56 | 08/09/20 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Amy Trombly
CEO | Chief Executive Officer | 57 | 27/09/19 |
Jay Birnbaum
BRD | Director/Board Member | 79 | 20/04/07 |
Director/Board Member | 64 | 19/09/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+34,00% | 704 Md | |
+26,01% | 577 Md | |
-7,75% | 348 Md | |
+18,53% | 327 Md | |
+4,95% | 288 Md | |
+15,09% | 234 Md | |
+4,93% | 198 Md | |
-9,78% | 194 Md | |
-4,89% | 147 Md |